BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26791603)

  • 1. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA; Tan CY; Gregory KJ; Christopoulos A; White PJ; May LT
    J Pharmacol Exp Ther; 2016 Apr; 357(1):36-44. PubMed ID: 26791603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of endogenous A
    Goulding J; May LT; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A
    Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
    Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the G protein-coupling selectivity of the native A
    Gao ZG; Inoue A; Jacobson KA
    Biochem Pharmacol; 2018 May; 151():201-213. PubMed ID: 29225130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A
    Jiang J; Seel CJ; Temirak A; Namasivayam V; Arridu A; Schabikowski J; Baqi Y; Hinz S; Hockemeyer J; Müller CE
    J Med Chem; 2019 Apr; 62(8):4032-4055. PubMed ID: 30835463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.
    Hajiahmadi S; Panjehpour M; Aghaei M; Shabani M
    Biochem Cell Biol; 2015 Aug; 93(4):321-9. PubMed ID: 25877700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.
    Li Q; Ye K; Blad CC; den Dulk H; Brouwer J; Ijzerman AP; Beukers MW
    J Pharmacol Exp Ther; 2007 Feb; 320(2):637-45. PubMed ID: 17077318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent-Labeled Selective Adenosine A
    Köse M; Gollos S; Karcz T; Fiene A; Heisig F; Behrenswerth A; Kieć-Kononowicz K; Namasivayam V; Müller CE
    J Med Chem; 2018 May; 61(10):4301-4316. PubMed ID: 29681156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptors and diabetes: Focus on the A(2B) adenosine receptor subtype.
    Merighi S; Borea PA; Gessi S
    Pharmacol Res; 2015 Sep; 99():229-36. PubMed ID: 26142494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
    Bruzzese L; Fromonot J; By Y; Durand-Gorde JM; Condo J; Kipson N; Guieu R; Fenouillet E; Ruf J
    Cell Signal; 2014 May; 26(5):1060-7. PubMed ID: 24486403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice.
    Eckle T; Grenz A; Laucher S; Eltzschig HK
    J Clin Invest; 2008 Oct; 118(10):3301-15. PubMed ID: 18787641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A
    Gao ZG; Jacobson KA
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S; Lacher SK; Seibt BF; Müller CE
    J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases.
    Eisenstein A; Patterson S; Ravid K
    J Cell Physiol; 2015 Dec; 230(12):2891-7. PubMed ID: 25975415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2B receptor modulates intestinal barrier function under hypoxic and ischemia/reperfusion conditions.
    Yang Y; Qiu Y; Wang W; Xiao W; Liang H; Zhang C; Yang H; Teitelbaum DH; Sun LH; Yang H
    Int J Clin Exp Pathol; 2014; 7(5):2006-18. PubMed ID: 24966910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.